Source: OncLive articles
In their closing thoughts, Mr Haumschild leads the panel in a discussion regarding treatments on the horizon for patients with relapsed/refractory multiple myeloma.
Read More
by | Feb 28, 2023 | Myeloma News | 0 comments
Source: OncLive articles
In their closing thoughts, Mr Haumschild leads the panel in a discussion regarding treatments on the horizon for patients with relapsed/refractory multiple myeloma.
Read More